Assen Dudov, Ivsan Chan. "Zolbetuximab in CLDN18.2-positive biliary tract cancer after prior systemic therapy: A prospective observational pilot cohort study of early outcomes, safety, and patient-reported quality of life.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e16174